What Will Puma Biotechnology Inc's $700 Million Man Do Next?
A sale to Johnson & Johnson, Pfizer, Roche, or one of the other big pharmas seems like the most likely outcome for Puma Biotechnology Inc.
FDA Approves Gilead Sciences Drug for 3 Cancers
The company's tablet, Zydelig, works by blocking signals inside some cancer cells that allow them to grow and survive.
Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings
AbbVie and GlaxoSmithKline are expected to report second quarter earnings this week. Here's what you need to know.